Variant report

Variant	nsv514139
Chromosome Location	chr3:17541196-17545644
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 119 )
Associated
traits (count: 75 )

Variant overlapped rSNPs/rCNVs (count:119 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs562569983	chr3:17541213-17541214	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs114893917	chr3:17541218-17541219	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs149490723	chr3:17541254-17541255	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs561515752	chr3:17541259-17541260	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs573917741	chr3:17541298-17541299	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs540948207	chr3:17541333-17541334	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs192727803	chr3:17541368-17541369	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs547353905	chr3:17541406-17541407	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs560641648	chr3:17541416-17541417	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs532500330	chr3:17541448-17541449	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs552295821	chr3:17541502-17541503	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs568292503	chr3:17541578-17541579	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs569287982	chr3:17541585-17541586	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs538001541	chr3:17541617-17541618	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs147135581	chr3:17541706-17541707	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs567947620	chr3:17541745-17541746	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs530503035	chr3:17541841-17541842	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs184690608	chr3:17541911-17541912	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs113396025	chr3:17541930-17541931	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs140336366	chr3:17541933-17541934	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs570671037	chr3:17541946-17541947	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs370558926	chr3:17541981-17541982	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs188465646	chr3:17542065-17542066	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs555892365	chr3:17542086-17542087	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs576086597	chr3:17542095-17542096	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs541988963	chr3:17542133-17542134	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs202005575	chr3:17542179-17542180	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs111919250	chr3:17542189-17542190	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs575056851	chr3:17542196-17542197	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs577213555	chr3:17542208-17542209	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs144088571	chr3:17542266-17542267	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs532695372	chr3:17542382-17542383	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs556886482	chr3:17542406-17542407	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs546175687	chr3:17542435-17542436	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs539312067	chr3:17542461-17542462	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs544235041	chr3:17542482-17542483	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs562782345	chr3:17542490-17542491	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs111714324	chr3:17542516-17542517	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs548303330	chr3:17542581-17542582	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs568237805	chr3:17542732-17542733	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs527449780	chr3:17542786-17542787	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs547284536	chr3:17542817-17542818	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs75579759	chr3:17542824-17542825	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs370902039	chr3:17542961-17542962	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs564022072	chr3:17542963-17542964	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs191390262	chr3:17543028-17543029	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs569587098	chr3:17543167-17543168	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs147315662	chr3:17543196-17543197	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs555465751	chr3:17543256-17543257	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs572178101	chr3:17543299-17543300	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:75)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Neuroblastoma	18923191	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
lymphocytic leukemia	21291569	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Esophageal cancer	20955586	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	21364760	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Breast cancer	17133270	CNVD
Ovarian cancer	21781307	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	23813976	CNVD
Bipolar disorder	19114987	CNVD
Cancer	20164919	CNVD

Chromatin state (count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:17522800-17541400	Weak transcription	Ovary	ovary
2	chr3:17523000-17541400	Weak transcription	Pancreas	Pancrea
3	chr3:17523000-17570000	Weak transcription	Spleen	Spleen
4	chr3:17523200-17556200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
5	chr3:17530600-17587600	Weak transcription	Sigmoid Colon	Sigmoid Colon
6	chr3:17532000-17542000	Weak transcription	A549	lung
7	chr3:17532600-17543800	Weak transcription	Liver	Liver
8	chr3:17533200-17550600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr3:17533400-17549800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
10	chr3:17533600-17547200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
11	chr3:17534000-17546800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
12	chr3:17534000-17559800	Weak transcription	Duodenum Smooth Muscle	Duodenum
13	chr3:17534200-17561600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
14	chr3:17535600-17552000	Weak transcription	Primary T cells from cord blood	blood
15	chr3:17536000-17549800	Weak transcription	Fetal Lung	lung
16	chr3:17536200-17555600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
17	chr3:17536400-17543400	Weak transcription	Primary hematopoietic stem cells	blood
18	chr3:17536400-17559800	Weak transcription	Adipose Nuclei	Adipose
19	chr3:17536400-17562600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
20	chr3:17536400-17568800	Weak transcription	GM12878-XiMat	blood
21	chr3:17536400-17574800	Weak transcription	Dnd41	blood
22	chr3:17536600-17544000	Weak transcription	Primary B cells from peripheral blood	blood
23	chr3:17536600-17544200	Weak transcription	Right Ventricle	heart
24	chr3:17536600-17547600	Weak transcription	Monocytes-CD14+_RO01746	blood
25	chr3:17536600-17559600	Weak transcription	Fetal Stomach	stomach
26	chr3:17536600-17560400	Weak transcription	Fetal Intestine Large	intestine
27	chr3:17536600-17561600	Weak transcription	Fetal Muscle Trunk	muscle
28	chr3:17536600-17562200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
29	chr3:17536600-17588000	Weak transcription	Left Ventricle	heart
30	chr3:17536800-17543400	Weak transcription	Fetal Intestine Small	intestine
31	chr3:17536800-17547800	Weak transcription	Primary monocytes fromperipheralblood	blood
32	chr3:17537200-17560000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr3:17538600-17543200	Weak transcription	Primary B cells from cord blood	blood
34	chr3:17538600-17546800	Weak transcription	Aorta	Aorta
35	chr3:17538600-17551600	Weak transcription	Placenta	Placenta
36	chr3:17540800-17541600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
37	chr3:17541000-17541200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
38	chr3:17541400-17541600	Enhancers	Ovary	ovary
39	chr3:17541400-17542200	Enhancers	Stomach Mucosa	stomach
40	chr3:17541600-17543000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
41	chr3:17541800-17545200	Weak transcription	Primary T helper cells fromperipheralblood	blood
42	chr3:17542000-17542600	Enhancers	A549	lung
43	chr3:17542000-17542600	Enhancers	HUVEC	blood vessel
44	chr3:17542000-17543000	Enhancers	NHEK	skin
45	chr3:17542200-17542800	Enhancers	Muscle Satellite Cultured Cells	--
46	chr3:17542200-17542800	Enhancers	HMEC	breast
47	chr3:17542600-17546800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
48	chr3:17542600-17546800	Weak transcription	HUVEC	blood vessel
49	chr3:17542600-17547200	Weak transcription	A549	lung
50	chr3:17542800-17546800	Weak transcription	Muscle Satellite Cultured Cells	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links